関連する実験動画
スーパーオキシドディスミュータゼとALS
1Academic Unit of Neuroscience, Charing Cross and Westminster Medical School, London, UK.
Lancet (London, England)
|December 17, 1994
まとめ
No abstract available in PubMed .
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
A novel mutation of SOD-1 (Gly 108 Val) in familial amyotrophic lateral sclerosis.
European journal of neurology·2013
Same author
The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study.
Journal of neurology, neurosurgery, and psychiatry·2008
Same author
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).
Neuroepidemiology·2007
Same author
Antioxidant treatment for amyotrophic lateral sclerosis / motor neuron disease.
The Cochrane database of systematic reviews·2007
Same author
Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis.
Brain : a journal of neurology·2006
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026